Compass Oncology; Associate Chair, Hematology Research Program, US Oncology Research
Hematology
Dr. Kathryn S. Kolibaba, MD
|
|
Give Review
Kathryn Kolibaba practices Hematology. She graduated from Oregon Health & Science University School of Medicine. She over the years received 1 awards: "Meaningful Use Stage 1 Certification". Kathryn Kolibaba is also a published physician. She has 13 paper published. The most recent paper is: Protein tyrosine kinases and cancer. She accepts Medicare payments and is registered with Medicare.gov.
Publications
- An open-label phase 2 trial of entospletinib (GS-9973), a selective Syk inhibitor, in chronic lymphocytic Leukemia.
- Molecular monitoring of response in patients with chronic myeloid Leukemia.
- Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell Malignancies.
- Results of a phase 2 study of bortezomib in patients with relapsed or refractory indolent Lymphoma.
- Catalytic domains of tyrosine kinases determine the phosphorylation sites within c-Cbl.
- CaM kinase IV regulates lineage commitment and survival of erythroid progenitors in a non-cell-autonomous manner.
- Efficacy of STI571, an abl tyrosine kinase inhibitor, in conjunction with other antileukemic agents against bcr-abl-positive cells.
- CRKL binding to BCR-ABL and BCR-ABL transformation.
- Protein tyrosine kinases and Cancer.
- Interactions of CBL with BCR-ABL and CRKL in BCR-ABL-transformed Myeloid cells.
- Direct binding of CRKL to BCR-ABL is not required for BCR-ABL transformation.
- NB4 cells show bilineage potential and an aberrant pattern of neutrophil secondary granule protein gene expression.
Schools
Oregon Health And Science University School Of Medicine
Yale New Haven Hospital
Oregon Health and Science University
Procedures Preformed
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
Education
-
Oregon Health & Science University -
Yale-New Haven Hospital -
Oregon Health & Science University School of Medicine
Drug Facts
| NPI NUMBER | 1932102720 | |
| NPPES Provider LastName | KOLIBABA | |
| NPPES Provider FirstName | KATHRYN | |
| NPPES Provider ZIPCode | 986846930 | |
| NPPES Provider State | WA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 455.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 50.0 | |
| Percent Opioid Claims | 10.99 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1932102720 |
| Last Name Of The Provider | KOLIBABA |
| First Name Of The Provider | KATHRYN |
| View All |
Similar Doctors
|
Dr. Matthew C. Brouns, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Clifford Pukel, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Lewis M. Steinberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gang Ye, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard B. Dobrow, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michaelann L. Liss, DO |
|
|
Dr. Fan Zhou, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Xing-Yue S. He, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Aruna K. Reddy, MD |
|
Dr. David A. Smith, MD
This Doctor is OpenDoctor Recommended.
|